摘要:
The invention provides inner quaternary N-triazinyl- ammonium salts of sulphonic acids, of the Formula 1, a method of preparation thereof and a use thereof as condensation reagents in condensation reactions.
摘要:
This invention provides a water soluble azo compound for yellow represented as a free acid by formula (1): [Chemical formula 1] (1) wherein A represents a hydroxyl group, a morpholino group, an amino group, an optionally substituted aliphatic amine residue, an optionally substituted aromatic amine residue, an optionally substituted phenoxy group, or an optionally substituted alkoxy group; R1 represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms; R2 represents a hydrogen atom, a nitro group, or a hydroxyl group; and n is an integer of 1 to 3, and an ink composition comprising the water soluble azo compound. The ink composition is highly stable, is suitable for ink jet printing, and can yield printed matter having a very high level of various fastness properties such as ozone resistance.
摘要:
The present invention is directed to Chemical compound according to formula (I)
wherein A1 and A2 independent from each other comprise a hydrophilic block (hi) and A3 comprises a hydrophobic block (ho) or wherein A1 and A2 independent from each other comprise a hydrophobic block (ho) and A3 comprises a hydrophilic block (hi).
摘要:
A compound of formula (1), or a pharmaceutically acceptable salt, solvate or in vivo hydrolysable ester thereof: and pharmaceutical compositions comprising these, all for use in the treatment of chemokine mediated diseases and disorders.
摘要:
Trisubstituted triazines can be synthesized from cyanuric chloride. These compounds are useful anti-tubulin agents for treating cancer and proliferative diseases.
摘要:
The present invention provides AGT inactivating compounds such as 7- or 9-substituted 8- aza- O 6 -benzylguanines of formula (III) or (IV), and related substituted O 6 -benzyl guanines, as well as pharmaceutical compositions comprising such compounds along with a pharmaceutically acceptable carrier. The present invention further provides a method of enhancing the chemotherapeutic treatment of tumour cells in a mammal with an antineoplastic alkylating agent which causes cytotoxic lesions at the O 6 - position of guanine, by administering to a mammal an effective amount of one of the aforesaid compounds, 2,4-diamino-6-benzyloxy-s-triazine, or 8-aza-O 6 -benzylguanine, and administering to the mammal an effective amount of an antineoplastic alkylating agent which causes cytotoxic lesions at the O 6 - position of guanine.